BamSEC and AlphaSense Join Forces
Learn More

Tcr2 Therapeutics Inc

Formerly NASDAQ: TCRR

Indentures Filter

EX-4.4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.6
from S-3ASR 39 pages Tcr2 Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3ASR 40 pages Tcr2 Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 202[·] Senior Debt Securities
12/34/56
EX-4.4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.6
from S-3 49 pages Tcr2 Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 48 pages Tcr2 Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Senior Debt Securities
12/34/56
EX-4.2
from S-1/A 2 pages The Corporation Shall Furnish Without Charge to Each Stockholder Who So Requests a Statement of the Powers, Designations, Preferences and Relative, Participating, Optional or Other Special Rights of Each Class of Stock of the Corporation or Series Thereof and the Qualifications, Limitations or Restrictions of Such Preferences and/or Rights. Such Requests Shall Be Made to the Corporation’s Secretary at the Principal Office of the Corporation. Keep This Certificate in a Safe Place. if It Is Lost, Stolen, or Destroyed the Corporation Will Require a Bond Indemnity as a Condition to the Issuance of a Replacement Certificate. the Following Abbreviations, When Used in the Inscription on the Face of This Certificate, Shall Be Construed as Though They Were Written Out in Full According to Applicable Laws or Regulations
12/34/56
EX-4.3
from S-1 11 pages Common Stock Warrant
12/34/56
EX-4.1
from S-1 59 pages Tcr2 Therapeutics Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.3
from DRS 11 pages Common Stock Warrant
12/34/56
EX-4.1
from DRS 59 pages Tcr2 Therapeutics Inc. Amended and Restated Investors’ Rights Agreement
12/34/56